Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022
17 avr. 2023 08h15 HE
|
Guardion Health Sciences, Inc.
HOUSTON, April 17, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences Hires Alantra, LLC as its Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value
06 mars 2023 08h00 HE
|
Guardion Health Sciences, Inc.
HOUSTON, March 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing Requirements
24 janv. 2023 16h05 HE
|
Guardion Health Sciences, Inc.
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it has received confirmation from The Nasdaq Stock Market...
Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023
06 janv. 2023 16h15 HE
|
Guardion Health Sciences, Inc.
HOUSTON, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it will effect a 1-for-50 reverse split of its common...
Guardion Health Sciences Announces Pricing of Aggregate $4.75 Million Institutional Private Placement of Series C and Series D Redeemable Preferred Stock
29 nov. 2022 17h06 HE
|
Guardion Health Sciences, Inc.
HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2022
14 nov. 2022 08h25 HE
|
Guardion Health Sciences, Inc.
Viactiv® Generated Net Revenues of Approximately $2.6 Million or 96% of Net Revenues for the Quarter Ended September 30, 2022 Company Announces Program to Evaluate Strategic Alternatives HOUSTON,...
Guardion Health Sciences Announces Clinical Results Indicating that Viactiv® Omega Boost™ Gel Bites Increase Omega-3 Levels in Just 4 weeks
06 oct. 2022 08h00 HE
|
Guardion Health Sciences, Inc.
New Viactiv Omega Boost™ Gel Bites Clinically Proven to Increase Omega-3 Levels by 51% in Just 4 Weeks First-Ever Clinically Proven Gel Bites, with a Tasty Fruit Flavor and No Fish Burps, are a...
Guardion Health Sciences Announces Financial Results for the Quarter Ended June 30, 2022
11 août 2022 08h20 HE
|
Guardion Health Sciences, Inc.
HOUSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
ISS Recommends Guardion Stockholders Vote for the Increase in Shares for Equity Plan and for the Reverse Stock Split at Guardion’s Upcoming 2022 Annual Stockholders’ Meeting
09 juin 2022 09h00 HE
|
Guardion Health Sciences, Inc.
HOUSTON, June 09, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced that independent proxy advisory firm ISS recommends that Guardion...
Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories
01 juin 2022 08h38 HE
|
Guardion Health Sciences, Inc.
HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced an agreement with OmegaQuant Laboratories (“OmegaQuant”) to provide...